サマリー

Market Analysis and Insights: Global and China Antibody Drugs Market
This report focuses on global and China Antibody Drugs market.
In 2020, the global Antibody Drugs market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Antibody Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Antibody Drugs Scope and Market Size
Antibody Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Antibody Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Monoclonal Antibodies
Antibody-Drug Conjugates
Polyclonal Antibodies

Segment by Application
Central Nervous System (CNS) Disorders
Cancers
Autoimmune Disorders
Cardiovascular Diseases

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Novartis
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson & Johnson
AbbVie
Eli Lilly
Pfizer
Bayer
GlaxoSmithKline
Sanofi

ページTOPに戻る

目次

1 Study Coverage
1.1 Antibody Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Antibody Drugs Market Size Growth Rate by Type
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug Conjugates
1.2.4 Polyclonal Antibodies
1.3 Market by Application
1.3.1 Global Antibody Drugs Market Size Growth Rate by Application
1.3.2 Central Nervous System (CNS) Disorders
1.3.3 Cancers
1.3.4 Autoimmune Disorders
1.3.5 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Antibody Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antibody Drugs Revenue 2016-2027
2.1.2 Global Antibody Drugs Sales 2016-2027
2.2 Global Antibody Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Antibody Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Antibody Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Antibody Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Antibody Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Antibody Drugs Revenue Forecast by Region (2022-2027)

3 Global Antibody Drugs Competitor Landscape by Players
3.1 Global Top Antibody Drugs Manufacturers by Sales
3.1.1 Global Antibody Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Antibody Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Antibody Drugs Manufacturers by Revenue
3.2.1 Key Antibody Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Antibody Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Antibody Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Antibody Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2020
3.2.6 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antibody Drugs Price by Manufacturers
3.4 Global Antibody Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antibody Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Antibody Drugs Market Size by Type (2016-2021)
4.1.1 Global Antibody Drugs Sales by Type (2016-2021)
4.1.2 Global Antibody Drugs Revenue by Type (2016-2021)
4.1.3 Antibody Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Antibody Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Antibody Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Antibody Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Antibody Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Antibody Drugs Market Size by Application (2016-2021)
5.1.1 Global Antibody Drugs Sales by Application (2016-2021)
5.1.2 Global Antibody Drugs Revenue by Application (2016-2021)
5.1.3 Antibody Drugs Price by Application (2016-2021)
5.2 Antibody Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Antibody Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Antibody Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Antibody Drugs Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Antibody Drugs Market Size YoY Growth 2016-2027
6.1.1 China Antibody Drugs Sales YoY Growth 2016-2027
6.1.2 China Antibody Drugs Revenue YoY Growth 2016-2027
6.1.3 China Antibody Drugs Market Share in Global Market 2016-2027
6.2 China Antibody Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Antibody Drugs Players by Sales (2016-2021)
6.2.2 China Top Antibody Drugs Players by Revenue (2016-2021)
6.3 China Antibody Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Antibody Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Antibody Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Antibody Drugs Price by Type (2016-2021)
6.4 China Antibody Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Antibody Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Antibody Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Antibody Drugs Price Forecast by Type (2022-2027)
6.5 China Antibody Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Antibody Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Antibody Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Antibody Drugs Price by Application (2016-2021)
6.6 China Antibody Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Antibody Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Antibody Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Antibody Drugs Price Forecast by Application (2022-2027)

7 North America
7.1 North America Antibody Drugs Market Size YoY Growth 2016-2027
7.2 North America Antibody Drugs Market Facts & Figures by Country
7.2.1 North America Antibody Drugs Sales by Country (2016-2021)
7.2.2 North America Antibody Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Antibody Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Antibody Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Antibody Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Antibody Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Antibody Drugs Market Size YoY Growth 2016-2027
9.2 Europe Antibody Drugs Market Facts & Figures by Country
9.2.1 Europe Antibody Drugs Sales by Country (2016-2021)
9.2.2 Europe Antibody Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Antibody Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Antibody Drugs Market Facts & Figures by Country
10.2.1 Latin America Antibody Drugs Sales by Country (2016-2021)
10.2.2 Latin America Antibody Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Antibody Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Antibody Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Antibody Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Antibody Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Antibody Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Amgen
12.2.1 Amgen Corporation Information
12.2.2 Amgen Description and Business Overview
12.2.3 Amgen Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amgen Antibody Drugs Products Offered
12.2.5 Amgen Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Corporation Information
12.3.2 Bristol-Myers Squibb Description and Business Overview
12.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bristol-Myers Squibb Antibody Drugs Products Offered
12.3.5 Bristol-Myers Squibb Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Corporation Information
12.4.2 F. Hoffmann-La Roche Description and Business Overview
12.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 F. Hoffmann-La Roche Antibody Drugs Products Offered
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Johnson & Johnson Antibody Drugs Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 AbbVie
12.6.1 AbbVie Corporation Information
12.6.2 AbbVie Description and Business Overview
12.6.3 AbbVie Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AbbVie Antibody Drugs Products Offered
12.6.5 AbbVie Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Corporation Information
12.7.2 Eli Lilly Description and Business Overview
12.7.3 Eli Lilly Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Eli Lilly Antibody Drugs Products Offered
12.7.5 Eli Lilly Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Antibody Drugs Products Offered
12.8.5 Pfizer Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Description and Business Overview
12.9.3 Bayer Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bayer Antibody Drugs Products Offered
12.9.5 Bayer Recent Development
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Corporation Information
12.10.2 GlaxoSmithKline Description and Business Overview
12.10.3 GlaxoSmithKline Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GlaxoSmithKline Antibody Drugs Products Offered
12.10.5 GlaxoSmithKline Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Antibody Drugs Products Offered
12.11.5 Novartis Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Antibody Drugs Industry Trends
13.2 Antibody Drugs Market Drivers
13.3 Antibody Drugs Market Challenges
13.4 Antibody Drugs Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer